AI-assisted screening detects early-stage lung cancer in high-risk never-smokers: Interim results from the local LC-SHIELD study

Encorafenib + cetuximab + chemotherapy improves PFS and OS as first-line therapy in BRAF V600E-mutant mCRC: Results from the phase 3 BREAKWATER trial

SEER-MHOS analysis supports the use of local estrogen therapy in breast cancer patients

Structured exercise improves survival outcomes in high-risk stage 2 or stage 3 colon cancer: Results from the CHALLENGE trial

PSA level post-treatment offers prognostic insight in mHSPC: Real-world analysis of the IRONMAN registry